Navigation Links
Better Pap Smear Follow-Up Needed Among Lower-Income Women
Date:8/20/2009

Disparities seen in screening rates, appropriate care in Canadian study

THURSDAY, Aug. 20 (HealthDay News) -- In the Canadian province of Ontario, fewer than half of women with abnormal Pap tests receive proper follow-up care and low-income women are less likely to be screened for cervical cancer than high-income women, a new study has found.

"Cervical cancer is one of the most preventable forms of cancer, yet in Ontario more than 1 million women have not been screened, and a disproportionate number of these women are living in lower-income communities," principal investigator Dr. Arlene Bierman, a physician at St. Michael's Hospital in Toronto, said in a news release from the hospital.

She and her colleagues found that less than 50 percent of women who had a Pap test that detected a low-grade abnormality received appropriate follow-up care within the recommended time period, including either a repeat test or a medical procedure called a colposcopy, which examines a woman's cervix and vagina. The low rate of follow-up in these women is cause for concern because they tend to be at greatest risk for eventually developing cervical cancer, the study authors noted.

The study also found that the overall rate of cervical cancer screening in Ontario was 69 percent, with screening rates of 61 percent for low-income women and 75 percent for high-income women.

"We need to make special efforts to reach women who are screened, but do not receive the necessary follow-up and may eventually fall through the cracks. To improve surveillance and treatment, we need a system that ensures all abnormal Pap tests are followed-up so that Ontario women can receive the best care possible," Bierman said in the news release.

The Project for an Ontario Women's Health Evidence-Based Report (POWER) study was a joint effort by St. Michael's Hospital and the Institute for Clinical Evaluative Sciences.

More informat
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Waist-to-hip ratio may better predict cardiovascular risk than body mass index
3. Informational handout key to giving parents a better understanding of CT radiation risks
4. Children of depressed moms do better when dad is involved, SLU researcher finds
5. Struggling male readers respond better to female teachers
6. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
7. Mothers Know Best: NFL Moms Team With Eddie George to Showcase a Better Way to a Healthier Lifestyle
8. Researchers Find Better Way to Deliver Blood Thinner
9. Clinical trials present better alternatives for dialysis patients
10. New nurses report job stress, need for better management
11. Hispanics hypertension better controlled with equal access to care
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Better Pap Smear Follow-Up Needed Among Lower-Income Women
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, has recently ... View website of AngelWeddingDress.com to find more details. ... online for a bridal party. AngelWeddingDress offers a variety ... Its maternity wedding dresses are specially designed for 2015. ...
(Date:1/22/2015)... January 22, 2015 A new white ... experience and person-centeredness in the long-term care environment as ... across the continuum. The paper, “The Power of Person-Centeredness ... perspectives and practices of the patient, resident and family ...
(Date:1/22/2015)... 2015 For over 20 years, Dr. David Cruz ... Vista area has treated just about every type of injury ... And for those same twenty-plus years, the team at ... injuries with the best possible doctor. With the combined ...
(Date:1/22/2015)... 2015 A study recently published ... journal Medicine & Science in Sports & Exercise ... help reduce gastrointestinal (GI) problems associated with physical ... in the double-blind, placebo-controlled study took 10 grams ...
(Date:1/22/2015)... City, Florida (PRWEB) January 22, 2015 IsoComforter, ... cold therapy machine with patented IsoTube design to treat specific ... has introduced the most progressive and easy to use patented ... treat post-operative and sports related orthopedic and muscle injuries. ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2
... Million- Annual Basic and Diluted Net Loss per Share of ... Share, or $4.77 per Diluted ShareSILVER SPRING, Md., Feb. 17 ... announced its financial results for the fourth quarter and year ... revenues for 2008 grew in excess of 30% for the ...
... Bradmer Pharmaceuticals Inc. (BMR.TSX), provided an update today ... Neuradiab(R) in the most advanced form of brain ... of Directors has recommended a review of strategic ... new projections of site initiation and patient enrollment ...
... Feb. 17 The Alliance for National Defense ... Defense to update or eliminate rules excluding servicewomen ... parental leave policies.The alliance is a non-profit organization ... military women. AND encourages and promotes the ...
... OSAKA, Japan and FLORHAM PARK, N.J., Feb. 17 ... year-long studies of velneperit, a novel neuropeptide Y (NPY) ... their primary endpoint of demonstrating a statistically significant reduction ... the potential for the NPY Y5 receptor as a ...
... solution for early detection of ear infectionsLENEXA, Kan., Feb. ... and tweeting away this winter on the topic of ... children,s visits to the emergency room."Parents often turn to ... infections," says Joe Kessinger of Innovia Medical, manufacturer of ...
... Host Quarterly Analyst Briefing on Thursday, 26 February ... at Frost & Sullivan is pleased ... on Medical Trends Impacting the Chemicals and Materials ... 2009 at 3 p.m. GMT.(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ...
Cached Medicine News:Health News:United Therapeutics Reports 2008 Fourth Quarter and Annual Financial Results 2Health News:United Therapeutics Reports 2008 Fourth Quarter and Annual Financial Results 3Health News:United Therapeutics Reports 2008 Fourth Quarter and Annual Financial Results 4Health News:United Therapeutics Reports 2008 Fourth Quarter and Annual Financial Results 5Health News:United Therapeutics Reports 2008 Fourth Quarter and Annual Financial Results 6Health News:United Therapeutics Reports 2008 Fourth Quarter and Annual Financial Results 7Health News:United Therapeutics Reports 2008 Fourth Quarter and Annual Financial Results 8Health News:United Therapeutics Reports 2008 Fourth Quarter and Annual Financial Results 9Health News:United Therapeutics Reports 2008 Fourth Quarter and Annual Financial Results 10Health News:Bradmer provides clinical trial update and announces evaluation of strategic alternatives 2Health News:Bradmer provides clinical trial update and announces evaluation of strategic alternatives 3Health News:Bradmer provides clinical trial update and announces evaluation of strategic alternatives 4Health News:AND Calls on DoD to Open All Military Units to Women, Grant Parental Leave to Service Members 2Health News:Shionogi Announces Positive Top-Line Efficacy Results from Year-Long Studies of Velneperit, a Novel NPY Y5 Receptor Antagonist Being Investigated for the Treatment of Obesity 2Health News:Shionogi Announces Positive Top-Line Efficacy Results from Year-Long Studies of Velneperit, a Novel NPY Y5 Receptor Antagonist Being Investigated for the Treatment of Obesity 3Health News:Shionogi Announces Positive Top-Line Efficacy Results from Year-Long Studies of Velneperit, a Novel NPY Y5 Receptor Antagonist Being Investigated for the Treatment of Obesity 4Health News:Shionogi Announces Positive Top-Line Efficacy Results from Year-Long Studies of Velneperit, a Novel NPY Y5 Receptor Antagonist Being Investigated for the Treatment of Obesity 5Health News:Shionogi Announces Positive Top-Line Efficacy Results from Year-Long Studies of Velneperit, a Novel NPY Y5 Receptor Antagonist Being Investigated for the Treatment of Obesity 6Health News:Video: Ear Infections Spark Online Conversations Among Concerned Parents 2Health News:Frost & Sullivan Helps You Know Your End-Market: Medical Trends Impacting the Chemicals and Materials Markets 2Health News:Frost & Sullivan Helps You Know Your End-Market: Medical Trends Impacting the Chemicals and Materials Markets 3
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, Inc. today ... Inc. for the compounding, packaging and distributing of its naltrexone ... the United States . KRS ... compounding naltrexone tablets in various strengths for individual patients in ...
(Date:1/23/2015)...  HyGreen, Inc., a leader in hand hygiene monitoring, today ... a subsidiary of Ascendis Health Limited, in ... hundreds of millions of patients around the world are ... from patient to patient via the unwashed hands of ...
(Date:1/23/2015)... Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that the number of ... compound, LB‑100, is being conducted, has been expanded from 1 ... M.D., the founder and President of Lixte, said that, "the ... site. Accrual of patients, however, was slower than projected. The ...
Breaking Medicine Technology:Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
... announces the release of its newest report, Capitalizing ... a sluggish economy and cuts being made to laboratory budgets, ... increase substantially over the next several years to $688.9 M ... of 2011. Suppliers of stem cell related products are ...
... (Nasdaq: TSPT ), a specialty pharmaceutical company ... that address important therapeutic needs in the field of ... first quarter 2009 on Wednesday, May 13, 2009, after ... begin at 5:00 p.m. ET (2:00 p.m. PT) on ...
Cached Medicine Technology:BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available 2BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available 3Transcept Pharmaceuticals to Report First Quarter 2009 Results 2Transcept Pharmaceuticals to Report First Quarter 2009 Results 3
... Every Bard® Biopsy Instrument and Needle is ... important goal: a large quality, reliable core ... performance, featuring ultra-sharp tips and polished surfaces ... selection of biopsy systems and needle sizes ...
... Used to obtain multiple core biopsies ... Quick-Core® Biopsy Needle design facilitates one-handed control. ... tissue sample. Beveled point stylet permits easy ... to surrounding tissue. Sharp cutting edge of ...
... Q-Track i Holter Monitoring System uses technology ... the worlds first true 12-lead digital Holter ... of any beat contained in the 24-hour ... ,The preprocessing work done by the Q-12 ...
... incorporates the iQ®200 Automated Urine Microscopy ... AX-4280 Automated Urine Chemistry Analyzer (AX-4280) ... and microscopic analysis. The iQ200 uses ... neural network, to classify and quantitate ...
Medicine Products: